| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation activator activity | 1.45e-07 | 15 | 66 | 4 | GO:0008494 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 3.45e-05 | 112 | 66 | 5 | GO:0090079 | |
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 1.60e-04 | 6 | 66 | 2 | GO:0008510 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF28 ZNF484 ZSCAN5DP ZNF273 ZNF724 ZNF721 ZBTB41 ZNF606 ZNF840P NKRF ZFP62 ZNF260 ZNF292 | 6.28e-04 | 1412 | 66 | 13 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF28 ZNF484 ZSCAN5DP ZNF273 ZNF724 ZNF721 ZBTB41 ZNF606 ZNF840P NKRF ZFP62 ZNF260 | 6.95e-04 | 1244 | 66 | 12 | GO:0000978 |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 8.20e-04 | 13 | 66 | 2 | GO:0140410 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF28 ZNF484 ZSCAN5DP ZNF273 ZNF724 ZNF721 ZBTB41 ZNF606 ZNF840P NKRF ZFP62 ZNF260 | 8.40e-04 | 1271 | 66 | 12 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | NCOR1 ZNF28 ZNF484 ZSCAN5DP ZNF273 ZNF724 ZNF721 ZBTB41 ZNF606 ZNF840P NKRF ZFP62 ZNF260 | 8.53e-04 | 1459 | 66 | 13 | GO:0000977 |
| GeneOntologyBiologicalProcess | female meiosis II | 1.34e-09 | 6 | 65 | 4 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 1.34e-09 | 6 | 65 | 4 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 1.34e-09 | 6 | 65 | 4 | GO:0061983 | |
| GeneOntologyBiologicalProcess | oocyte maturation | 3.68e-07 | 47 | 65 | 5 | GO:0001556 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 1.27e-06 | 26 | 65 | 4 | GO:0045836 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 2.01e-06 | 29 | 65 | 4 | GO:0045948 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 2.65e-06 | 31 | 65 | 4 | GO:0070935 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear division | 3.87e-06 | 75 | 65 | 5 | GO:0051785 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 5.49e-06 | 37 | 65 | 4 | GO:0051446 | |
| GeneOntologyBiologicalProcess | regulation of meiotic cell cycle | 6.01e-06 | 82 | 65 | 5 | GO:0051445 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 1.00e-05 | 91 | 65 | 5 | GO:0006446 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 1.21e-05 | 45 | 65 | 4 | GO:0040020 | |
| GeneOntologyBiologicalProcess | oocyte development | 1.51e-05 | 99 | 65 | 5 | GO:0048599 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 1.83e-05 | 103 | 65 | 5 | GO:0009994 | |
| GeneOntologyBiologicalProcess | cell maturation | 2.07e-05 | 267 | 65 | 7 | GO:0048469 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 2.17e-05 | 52 | 65 | 4 | GO:0007143 | |
| GeneOntologyBiologicalProcess | translational initiation | 6.04e-05 | 132 | 65 | 5 | GO:0006413 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 1.02e-04 | 77 | 65 | 4 | GO:0048255 | |
| GeneOntologyBiologicalProcess | anatomical structure maturation | 1.22e-04 | 354 | 65 | 7 | GO:0071695 | |
| GeneOntologyBiologicalProcess | oogenesis | 1.33e-04 | 156 | 65 | 5 | GO:0048477 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 1.64e-04 | 87 | 65 | 4 | GO:1902373 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 1.72e-04 | 88 | 65 | 4 | GO:0043489 | |
| GeneOntologyBiologicalProcess | regulation of nuclear division | 2.10e-04 | 172 | 65 | 5 | GO:0051783 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 2.92e-04 | 101 | 65 | 4 | GO:1902369 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 3.38e-04 | 418 | 65 | 7 | GO:0009895 | |
| GeneOntologyBiologicalProcess | developmental maturation | 4.53e-04 | 439 | 65 | 7 | GO:0021700 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 4.78e-04 | 115 | 65 | 4 | GO:1903312 | |
| GeneOntologyBiologicalProcess | regulation of catabolic process | CUL3 NCOR1 DAZ4 PRKAA2 PBK NQO1 ANGPTL3 DAZ1 DAZ3 SLC4A4 DAZ2 TRIM23 | 4.78e-04 | 1252 | 65 | 12 | GO:0009894 |
| GeneOntologyBiologicalProcess | positive regulation of reproductive process | 5.27e-04 | 118 | 65 | 4 | GO:2000243 | |
| GeneOntologyBiologicalProcess | female gamete generation | 6.89e-04 | 223 | 65 | 5 | GO:0007292 | |
| GeneOntologyBiologicalProcess | regulation of purine nucleotide catabolic process | 1.04e-03 | 63 | 65 | 3 | GO:0033121 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide catabolic process | 1.04e-03 | 63 | 65 | 3 | GO:0030811 | |
| GeneOntologyBiologicalProcess | regulation of glycolytic process | 1.04e-03 | 63 | 65 | 3 | GO:0006110 | |
| GeneOntologyBiologicalProcess | regulation of reproductive process | 1.17e-03 | 251 | 65 | 5 | GO:2000241 | |
| HumanPheno | Y-linked inheritance | 2.44e-05 | 18 | 17 | 3 | HP:0001450 | |
| HumanPheno | Oligozoospermia | 3.45e-05 | 59 | 17 | 4 | HP:0000798 | |
| MousePheno | absent ovarian follicles | 2.50e-05 | 51 | 47 | 4 | MP:0002777 | |
| Domain | Znf_C2H2 | ZXDC ZNF28 ZNF484 ZSCAN5DP ZNF273 ZNF721 ZBTB41 ZMAT4 ZNF606 TRIM23 ZFP62 ZNF260 ZNF292 | 2.75e-06 | 805 | 64 | 13 | IPR007087 |
| Domain | Znf_C2H2-like | ZXDC ZNF28 ZNF484 ZSCAN5DP ZNF273 ZNF721 ZBTB41 ZMAT4 ZNF606 ZFP62 ZNF260 ZNF292 | 1.41e-05 | 796 | 64 | 12 | IPR015880 |
| Domain | ZnF_C2H2 | ZXDC ZNF28 ZNF484 ZSCAN5DP ZNF273 ZNF721 ZBTB41 ZMAT4 ZNF606 ZFP62 ZNF260 ZNF292 | 1.64e-05 | 808 | 64 | 12 | SM00355 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZXDC ZNF28 ZNF484 ZSCAN5DP ZNF273 ZNF721 ZBTB41 ZNF606 ZFP62 ZNF260 ZNF292 | 2.13e-05 | 694 | 64 | 11 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZXDC ZNF28 ZNF484 ZSCAN5DP ZNF273 ZNF721 ZBTB41 ZNF606 ZFP62 ZNF260 ZNF292 | 5.82e-05 | 775 | 64 | 11 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZXDC ZNF28 ZNF484 ZSCAN5DP ZNF273 ZNF721 ZBTB41 ZNF606 ZFP62 ZNF260 ZNF292 | 5.96e-05 | 777 | 64 | 11 | PS00028 |
| Domain | - | ZXDC ZNF28 ZNF484 ZNF273 ZNF721 ZBTB41 ZNF606 ZFP62 ZNF260 ZNF292 | 9.70e-05 | 679 | 64 | 10 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF28 ZNF484 ZSCAN5DP ZNF273 ZNF721 ZBTB41 ZNF606 ZFP62 ZNF260 ZNF292 | 1.15e-04 | 693 | 64 | 10 | PF00096 |
| Domain | BRK | 1.72e-04 | 6 | 64 | 2 | SM00592 | |
| Domain | BRK_domain | 1.72e-04 | 6 | 64 | 2 | IPR006576 | |
| Domain | BRK | 1.72e-04 | 6 | 64 | 2 | PF07533 | |
| Domain | Band3_cytoplasmic_dom | 4.10e-04 | 9 | 64 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 4.10e-04 | 9 | 64 | 2 | PF07565 | |
| Domain | - | 4.10e-04 | 9 | 64 | 2 | 3.40.1100.10 | |
| Domain | HCO3_cotransp | 5.11e-04 | 10 | 64 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 5.11e-04 | 10 | 64 | 2 | IPR011531 | |
| Domain | PTrfase/Anion_transptr | 5.11e-04 | 10 | 64 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 5.11e-04 | 10 | 64 | 2 | IPR003020 | |
| Domain | zf-C2H2_6 | 7.12e-04 | 314 | 64 | 6 | PF13912 | |
| Domain | Chromo_domain | 3.04e-03 | 24 | 64 | 2 | IPR023780 | |
| Domain | Chromo | 3.56e-03 | 26 | 64 | 2 | PF00385 | |
| Domain | CHROMO_1 | 4.13e-03 | 28 | 64 | 2 | PS00598 | |
| Domain | CHROMO_2 | 4.13e-03 | 28 | 64 | 2 | PS50013 | |
| Domain | RA | 5.04e-03 | 31 | 64 | 2 | SM00314 | |
| Domain | SNF2_N | 5.37e-03 | 32 | 64 | 2 | IPR000330 | |
| Domain | Chromodomain-like | 5.37e-03 | 32 | 64 | 2 | IPR016197 | |
| Domain | SNF2_N | 5.37e-03 | 32 | 64 | 2 | PF00176 | |
| Domain | RRM_1 | 5.64e-03 | 208 | 64 | 4 | PF00076 | |
| Domain | Chromo/shadow_dom | 5.70e-03 | 33 | 64 | 2 | IPR000953 | |
| Domain | CHROMO | 5.70e-03 | 33 | 64 | 2 | SM00298 | |
| Domain | RRM | 6.54e-03 | 217 | 64 | 4 | SM00360 | |
| Pathway | WP_OVARIAN_INFERTILITY | 1.37e-07 | 35 | 50 | 5 | MM15948 | |
| Pathway | WP_MALE_INFERTILITY | 1.17e-05 | 145 | 50 | 6 | M39856 | |
| Pathway | REACTOME_NUCLEAR_SIGNALING_BY_ERBB4 | 1.94e-04 | 32 | 50 | 3 | M571 | |
| Pubmed | 1.10e-13 | 14 | 66 | 6 | 15378723 | ||
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 1.18e-11 | 4 | 66 | 4 | 15066457 | |
| Pubmed | 1.18e-11 | 4 | 66 | 4 | 7670487 | ||
| Pubmed | 1.18e-11 | 4 | 66 | 4 | 11694340 | ||
| Pubmed | 1.18e-11 | 4 | 66 | 4 | 9321470 | ||
| Pubmed | 1.18e-11 | 4 | 66 | 4 | 19223287 | ||
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 1.18e-11 | 4 | 66 | 4 | 11095434 | |
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 1.18e-11 | 4 | 66 | 4 | 26232607 | |
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 1.18e-11 | 4 | 66 | 4 | 11688365 | |
| Pubmed | 1.18e-11 | 4 | 66 | 4 | 12752250 | ||
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 1.18e-11 | 4 | 66 | 4 | 11883873 | |
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 1.18e-11 | 4 | 66 | 4 | 10936047 | |
| Pubmed | [Study on DAZ gene copy deletion in severe oligozoospermia sperm donor for ICSI]. | 1.18e-11 | 4 | 66 | 4 | 16963411 | |
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 1.18e-11 | 4 | 66 | 4 | 12801575 | |
| Pubmed | 5.90e-11 | 5 | 66 | 4 | 23579190 | ||
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 5.90e-11 | 5 | 66 | 4 | 22021443 | |
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 5.90e-11 | 5 | 66 | 4 | 9288969 | |
| Pubmed | 5.90e-11 | 5 | 66 | 4 | 20008336 | ||
| Pubmed | 5.90e-11 | 5 | 66 | 4 | 23456578 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 5.90e-11 | 5 | 66 | 4 | 8679003 | |
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 5.90e-11 | 5 | 66 | 4 | 10903443 | |
| Pubmed | 5.90e-11 | 5 | 66 | 4 | 9143498 | ||
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 5.90e-11 | 5 | 66 | 4 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 5.90e-11 | 5 | 66 | 4 | 8845845 | |
| Pubmed | 5.90e-11 | 5 | 66 | 4 | 11058556 | ||
| Pubmed | AZFc partial deletions in Chilean men with severe spermatogenic failure. | 5.90e-11 | 5 | 66 | 4 | 17416365 | |
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 5.90e-11 | 5 | 66 | 4 | 19783541 | |
| Pubmed | 5.90e-11 | 5 | 66 | 4 | 22293198 | ||
| Pubmed | 5.90e-11 | 5 | 66 | 4 | 17761180 | ||
| Pubmed | 5.90e-11 | 5 | 66 | 4 | 19468308 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 5.90e-11 | 5 | 66 | 4 | 12200456 | |
| Pubmed | 5.90e-11 | 5 | 66 | 4 | 11514340 | ||
| Pubmed | 5.90e-11 | 5 | 66 | 4 | 11089564 | ||
| Pubmed | 5.90e-11 | 5 | 66 | 4 | 23298641 | ||
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 5.90e-11 | 5 | 66 | 4 | 22223682 | |
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 5.90e-11 | 5 | 66 | 4 | 10393944 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 5.90e-11 | 5 | 66 | 4 | 8968756 | |
| Pubmed | 5.90e-11 | 5 | 66 | 4 | 8968755 | ||
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 5.90e-11 | 5 | 66 | 4 | 30380414 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 5.90e-11 | 5 | 66 | 4 | 26411291 | |
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 5.90e-11 | 5 | 66 | 4 | 23223451 | |
| Pubmed | 5.90e-11 | 5 | 66 | 4 | 34985827 | ||
| Pubmed | 5.90e-11 | 5 | 66 | 4 | 11804965 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 5.90e-11 | 5 | 66 | 4 | 14648873 | |
| Pubmed | 5.90e-11 | 5 | 66 | 4 | 8896558 | ||
| Pubmed | 5.90e-11 | 5 | 66 | 4 | 9700189 | ||
| Pubmed | 5.90e-11 | 5 | 66 | 4 | 21270429 | ||
| Pubmed | 5.90e-11 | 5 | 66 | 4 | 8661148 | ||
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 1.77e-10 | 6 | 66 | 4 | 15066460 | |
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 1.77e-10 | 6 | 66 | 4 | 18452650 | |
| Pubmed | 1.77e-10 | 6 | 66 | 4 | 24086306 | ||
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 1.77e-10 | 6 | 66 | 4 | 19247806 | |
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 1.77e-10 | 6 | 66 | 4 | 31355046 | |
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 1.77e-10 | 6 | 66 | 4 | 23417416 | |
| Pubmed | 1.77e-10 | 6 | 66 | 4 | 32170089 | ||
| Pubmed | 1.77e-10 | 6 | 66 | 4 | 16278232 | ||
| Pubmed | 1.77e-10 | 6 | 66 | 4 | 20157580 | ||
| Pubmed | 1.77e-10 | 6 | 66 | 4 | 17219433 | ||
| Pubmed | 1.77e-10 | 6 | 66 | 4 | 28496037 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 1.77e-10 | 6 | 66 | 4 | 26077710 | |
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 1.77e-10 | 6 | 66 | 4 | 16001084 | |
| Pubmed | 1.77e-10 | 6 | 66 | 4 | 32962040 | ||
| Pubmed | 1.77e-10 | 6 | 66 | 4 | 17526644 | ||
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 1.77e-10 | 6 | 66 | 4 | 1869307 | |
| Pubmed | 1.77e-10 | 6 | 66 | 4 | 11390979 | ||
| Pubmed | 1.77e-10 | 6 | 66 | 4 | 27632217 | ||
| Pubmed | 1.77e-10 | 6 | 66 | 4 | 1638086 | ||
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 1.77e-10 | 6 | 66 | 4 | 14611632 | |
| Pubmed | 4.12e-10 | 7 | 66 | 4 | 10857750 | ||
| Pubmed | 4.12e-10 | 7 | 66 | 4 | 11410654 | ||
| Pubmed | 4.12e-10 | 7 | 66 | 4 | 15081113 | ||
| Pubmed | 4.12e-10 | 7 | 66 | 4 | 22699423 | ||
| Pubmed | 4.12e-10 | 7 | 66 | 4 | 11604102 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 4.12e-10 | 7 | 66 | 4 | 9588208 | |
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 4.12e-10 | 7 | 66 | 4 | 26826184 | |
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 4.12e-10 | 7 | 66 | 4 | 16946704 | |
| Pubmed | 8.23e-10 | 8 | 66 | 4 | 10951504 | ||
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 8.23e-10 | 8 | 66 | 4 | 32339196 | |
| Pubmed | 8.23e-10 | 8 | 66 | 4 | 33749946 | ||
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 8.23e-10 | 8 | 66 | 4 | 23204224 | |
| Pubmed | 8.23e-10 | 8 | 66 | 4 | 29883445 | ||
| Pubmed | 8.23e-10 | 8 | 66 | 4 | 10823932 | ||
| Pubmed | 8.23e-10 | 8 | 66 | 4 | 22621333 | ||
| Pubmed | 8.23e-10 | 8 | 66 | 4 | 32686646 | ||
| Pubmed | 8.23e-10 | 8 | 66 | 4 | 11869379 | ||
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 1.48e-09 | 9 | 66 | 4 | 16310179 | |
| Pubmed | 1.48e-09 | 9 | 66 | 4 | 20159962 | ||
| Pubmed | A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. | 1.48e-09 | 9 | 66 | 4 | 26378784 | |
| Pubmed | Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL. | 1.48e-09 | 9 | 66 | 4 | 19695304 | |
| Pubmed | 1.48e-09 | 9 | 66 | 4 | 28235998 | ||
| Pubmed | 2.42e-09 | 29 | 66 | 5 | 34175335 | ||
| Pubmed | 2.46e-09 | 10 | 66 | 4 | 10601091 | ||
| Pubmed | 2.46e-09 | 10 | 66 | 4 | 31234534 | ||
| Pubmed | Tesmin transcription is regulated differently during male and female meiosis. | 2.46e-09 | 10 | 66 | 4 | 14648882 | |
| Pubmed | MAX controls meiotic entry in sexually undifferentiated germ cells. | 2.46e-09 | 10 | 66 | 4 | 38433229 | |
| Pubmed | 2.46e-09 | 10 | 66 | 4 | 9922113 | ||
| Pubmed | 2.46e-09 | 10 | 66 | 4 | 23810942 | ||
| Pubmed | 2.46e-09 | 10 | 66 | 4 | 12837688 | ||
| Pubmed | NANOS2 suppresses the cell cycle by repressing mTORC1 activators in embryonic male germ cells. | 3.86e-09 | 11 | 66 | 4 | 34401671 | |
| Pubmed | 5.79e-09 | 12 | 66 | 4 | 32054698 | ||
| Cytoband | Yq11.223 | 1.03e-05 | 93 | 66 | 4 | Yq11.223 | |
| Cytoband | 9q22.31 | 6.98e-04 | 27 | 66 | 2 | 9q22.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p16 | 7.24e-04 | 121 | 66 | 3 | chr2p16 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYq11 | 1.07e-03 | 311 | 66 | 4 | chrYq11 | |
| Cytoband | 19q13.4 | 5.84e-03 | 79 | 66 | 2 | 19q13.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq24 | 6.13e-03 | 81 | 66 | 2 | chrXq24 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZXDC ZNF28 ZNF484 ZSCAN5DP ZNF273 ZNF721 ZBTB41 ZNF606 ZFP62 ZNF260 ZNF292 | 2.12e-06 | 718 | 48 | 11 | 28 |
| GeneFamily | RNA binding motif containing | 2.43e-03 | 213 | 48 | 4 | 725 | |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 1.68e-08 | 12 | 65 | 4 | MM742 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 1.68e-08 | 12 | 65 | 4 | MM781 | |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 2.94e-07 | 23 | 65 | 4 | MM1293 | |
| Coexpression | MATZUK_SPERMATOGONIA | 1.03e-06 | 31 | 65 | 4 | MM765 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 1.33e-06 | 33 | 65 | 4 | MM701 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 3.52e-06 | 93 | 65 | 5 | MM1185 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_ENSHEATHING_GLIA | 9.97e-06 | 115 | 65 | 5 | M39290 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K4ME3 | 1.50e-05 | 449 | 65 | 8 | M2013 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K4ME3 | 3.09e-05 | 497 | 65 | 8 | MM863 | |
| Coexpression | IBRAHIM_NRF2_UP | 5.06e-05 | 533 | 65 | 8 | M42510 | |
| Coexpression | STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP | 5.73e-05 | 84 | 65 | 4 | M2103 | |
| Coexpression | MADAN_DPPA4_TARGETS | 6.28e-05 | 86 | 65 | 4 | MM1312 | |
| Coexpression | GSE13411_NAIVE_VS_MEMORY_BCELL_UP | 1.16e-04 | 192 | 65 | 5 | M3245 | |
| Coexpression | GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_UP | 1.34e-04 | 198 | 65 | 5 | M8407 | |
| Coexpression | GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 1.34e-04 | 198 | 65 | 5 | M7200 | |
| Coexpression | GSE27786_CD8_TCELL_VS_NEUTROPHIL_UP | 1.37e-04 | 199 | 65 | 5 | M4846 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_DC_UP | 1.37e-04 | 199 | 65 | 5 | M4475 | |
| Coexpression | GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP | 1.40e-04 | 200 | 65 | 5 | M328 | |
| Coexpression | GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_UP | 1.40e-04 | 200 | 65 | 5 | M5831 | |
| Coexpression | GSE27786_CD4_TCELL_VS_NKCELL_UP | 1.40e-04 | 200 | 65 | 5 | M4822 | |
| Coexpression | GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_UP | 1.40e-04 | 200 | 65 | 5 | M7135 | |
| Coexpression | GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP | 1.40e-04 | 200 | 65 | 5 | M6004 | |
| Coexpression | KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP | 1.40e-04 | 200 | 65 | 5 | M3020 | |
| Coexpression | TIEN_INTESTINE_PROBIOTICS_24HR_DN | 1.96e-04 | 215 | 65 | 5 | M19666 | |
| Coexpression | DELYS_THYROID_CANCER_DN | 2.85e-04 | 233 | 65 | 5 | M13273 | |
| ToppCell | IPF-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 3.21e-07 | 190 | 64 | 6 | c29dabf0826663b9d6df51a7af9b76592090e44c | |
| ToppCell | droplet-Kidney-nan-18m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-06 | 184 | 64 | 5 | e02859bbac36dbbd55d7ae8cb5e46b764d7c6381 | |
| ToppCell | IPF-Epithelial-Goblet|IPF / Disease state, Lineage and Cell class | 7.94e-06 | 190 | 64 | 5 | e41dd5a997ad9952810ffecb57737c03ea1d88b3 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 191 | 64 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.14e-06 | 191 | 64 | 5 | b9ef6d82b86271b7e0875a399bb9aae84ef5bad3 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 191 | 64 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 191 | 64 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.78e-06 | 194 | 64 | 5 | d429bb5e422a07bd92f0dc48cd51528e8b7d9a72 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.78e-06 | 194 | 64 | 5 | bffdf6db0bf3fb338e7bb0789ae7dcde1fce0094 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.78e-06 | 194 | 64 | 5 | 408dfc7060095972a54ae37ae8105521df6fbbee | |
| ToppCell | Biopsy_Other_PF-Epithelial-MUC5B+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 9.93e-06 | 199 | 64 | 5 | afd0df242a93f176438309668a9487be1250d9ca | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Club|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.02e-05 | 200 | 64 | 5 | 85f946dd3831acf3488c87efba96689cc2667c3a | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-05 | 200 | 64 | 5 | 8a44a4f7ea9358f2194a490e79601c98ff7fdcb0 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.02e-05 | 200 | 64 | 5 | 30d428510c68da96c7c8cfd472f449ebb9631132 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.36e-05 | 143 | 64 | 4 | 28e936c298a45f88d14f0146caf3d5a22d483cd5 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.80e-05 | 152 | 64 | 4 | 1b2a39ae159e79f1fb18d6d164bd7acab5299fca | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.09e-05 | 159 | 64 | 4 | 22427ad4ad2e797e4664e7a7b0514094f22a18b2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.70e-05 | 162 | 64 | 4 | 9b1c07f0af657095379380c39d763cab0ad73e74 | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.56e-05 | 166 | 64 | 4 | 3b750d4023a0a09d86113aae5a97d84391f7b482 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D122|Adult / Lineage, Cell type, age group and donor | 9.78e-05 | 167 | 64 | 4 | 6efbb2ef6adc8da5dd67210969f825f5cc8ed022 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.00e-04 | 168 | 64 | 4 | 5e721268f0baa51d3f640f7f4c41db769ebef210 | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 168 | 64 | 4 | ce9fae8b295c668b0959d5007a8bcd401d80e258 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-04 | 169 | 64 | 4 | cfc9ff103d13a2d5eacc457e800f53fdd29f7738 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.07e-04 | 171 | 64 | 4 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.07e-04 | 171 | 64 | 4 | b7cddb8f726a43fb8a37f3e67a3f722e2178fd7a | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-04 | 174 | 64 | 4 | c9d4e375dedd2b099a9ed70ec38ff35bbb0ce48a | |
| ToppCell | LPS-antiTNF-Lymphocytic_B|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 174 | 64 | 4 | cc493654ea3517bc6a145c7f787f304929636f86 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-04 | 174 | 64 | 4 | 1463c98f8f519dd030587abbdbeb1b4e1bca5dd1 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-04 | 174 | 64 | 4 | d421c0069d24cb560a3a429929e3cd1eceaeabcf | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 174 | 64 | 4 | 9eb3504f9340517ef5d056503044fbdb9ffeb714 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 174 | 64 | 4 | b4c2d1c029fcd0d4926aa79a5b789c713919dcf3 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.15e-04 | 174 | 64 | 4 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | (03)_Secretory|World / shred by cell type and Timepoint | 1.20e-04 | 176 | 64 | 4 | cb7b1945788196ca79007f0768b6576ec885a0e5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-04 | 176 | 64 | 4 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-04 | 177 | 64 | 4 | c82332c5f656aa26513e4f7525d5d4d733019725 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.22e-04 | 177 | 64 | 4 | 779ba86f53650772755b52460be03f18bb204e55 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.22e-04 | 177 | 64 | 4 | 0f210cfb61b873c5fd77dc17eadf4d017306500e | |
| ToppCell | LPS_only-Lymphocytic_B|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-04 | 177 | 64 | 4 | 5ed65e08d773d157840317c72e0d43c261d438d4 | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells-B-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-04 | 177 | 64 | 4 | 8a955a7ab84c434f9ad4b467246b8be3cb479406 | |
| ToppCell | ILEUM-inflamed-(9)_Enteric_neurons|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.25e-04 | 178 | 64 | 4 | d9142151819afb0dc22bfb32a9c9dba5f553067d | |
| ToppCell | normal-na-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.25e-04 | 178 | 64 | 4 | fa3585383a1e7da460c88a802aaa81246d681b6b | |
| ToppCell | ILEUM-inflamed-(9)_Neuro_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.25e-04 | 178 | 64 | 4 | 611504b0a9e6318b18fba83787b03f9245c82252 | |
| ToppCell | Club_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.25e-04 | 178 | 64 | 4 | be64d4be23fb96a4cdd7980c58880fdfe817747f | |
| ToppCell | wk_08-11-Epithelial-PNS-Proliferating_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.28e-04 | 179 | 64 | 4 | ab23fee9adab1e63d5b5cd9faba6b9a92beef425 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 179 | 64 | 4 | 7ae67e1c09a4ce9b3bcec4c48ee9cf2b1cb4e339 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma-Plasmablasts|Lung / Manually curated celltypes from each tissue | 1.28e-04 | 179 | 64 | 4 | 3fa75eec3e86fd1797eaa33362257df7f9b2a0bf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-04 | 180 | 64 | 4 | 42f48e646fc6e72ad3cce72409ace3a0b64020a2 | |
| ToppCell | Control-Epithelial-Goblet|Control / Disease state, Lineage and Cell class | 1.31e-04 | 180 | 64 | 4 | 5293d23b8b8ea587239ffde561b70bad01632521 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.36e-04 | 182 | 64 | 4 | 9ba85f621a846531a2a7861e9df695d288c9e149 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 182 | 64 | 4 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 182 | 64 | 4 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.39e-04 | 183 | 64 | 4 | 317b756378a9efd8ecb754acf7273f83f996e106 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-04 | 183 | 64 | 4 | 29b62dd542bc3f8df843998f577724f3818d4271 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-04 | 184 | 64 | 4 | d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5 | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.42e-04 | 184 | 64 | 4 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 185 | 64 | 4 | 3d1353dbcb60e2531ef67e1bd218b7bc4d7c7c9b | |
| ToppCell | Control-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 1.45e-04 | 185 | 64 | 4 | 9a793e6016295a63820e9d7563f195494ac692e7 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 185 | 64 | 4 | 995a8ddc3fd8e6879d8b5de8cbdefe232d34833b | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-04 | 185 | 64 | 4 | f607b6ee579562e2f92103fa5c7053df0170a229 | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-04 | 185 | 64 | 4 | 317f2c854f00aa5957319b818c85eeed7d72ec7f | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-04 | 185 | 64 | 4 | 7bb8fdfe04f85d25056380ec58222366de323a21 | |
| ToppCell | COPD-Lymphoid-B|World / Disease state, Lineage and Cell class | 1.45e-04 | 185 | 64 | 4 | 22891ed75e25ef30dfa541cb82d85e08ce07e7d9 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 186 | 64 | 4 | adba5647a2feaba8e361dc1020d2f2dc4ce36b16 | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 1.48e-04 | 186 | 64 | 4 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.51e-04 | 187 | 64 | 4 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 187 | 64 | 4 | 99724aa3dbdcb073ea3bfe80cc825ecae5495db8 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 188 | 64 | 4 | c2101ded71fb16b8ddbc1f883911b1ed2a533ffc | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 188 | 64 | 4 | 3b8b9161f0fdcbde302ce5b4c0bc874628211109 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 188 | 64 | 4 | 921a2c9212a0f2a00fd72c594d80924f27e8b9b7 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.54e-04 | 188 | 64 | 4 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 189 | 64 | 4 | 45b9d00a4968fb22207d95228cdcf022afe1e50b | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 189 | 64 | 4 | 8382d331e01e83591ba9c8ea83edbf2436c18b17 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.57e-04 | 189 | 64 | 4 | 8130102c41b2978a8b83f765ce383f836a464795 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.61e-04 | 190 | 64 | 4 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | IPF-Lymphoid-T|IPF / Disease state, Lineage and Cell class | 1.61e-04 | 190 | 64 | 4 | d57df208aaf7a5554899bb9107c80b443fd0cf93 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 190 | 64 | 4 | e2481bd5166fde2cdc0c3824894f2bccb8294fdd | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.61e-04 | 190 | 64 | 4 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 1.61e-04 | 190 | 64 | 4 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.64e-04 | 191 | 64 | 4 | 95ae42d145adb478d886a2259baacc713cd6587b | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.64e-04 | 191 | 64 | 4 | 054fa0493b00149313c243d39cf39a264044f074 | |
| ToppCell | Control-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 1.67e-04 | 192 | 64 | 4 | f95fb188aa642f3d0618242a770e7c4b70544adb | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal-Glial_mature|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-04 | 192 | 64 | 4 | ac507fd7cf3b3e521a15ef03bb4e81eb23807985 | |
| ToppCell | COPD-Lymphoid-T|World / Disease state, Lineage and Cell class | 1.67e-04 | 192 | 64 | 4 | eb4909574fb5fc91399463523e2737095773200a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-04 | 192 | 64 | 4 | 7ab626a516b07d899175ff12f1c8257688324e4b | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-04 | 192 | 64 | 4 | 24f40dadec04f4f99c31000fa9f09d07148fa190 | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 1.67e-04 | 192 | 64 | 4 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | IPF-Lymphoid-T|World / Disease state, Lineage and Cell class | 1.67e-04 | 192 | 64 | 4 | b25ba1f3bc842c22602b2aeed3b1b5082863e4fa | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-04 | 192 | 64 | 4 | 71e04e197825856c6d4278fc76c58ab17ffa2387 | |
| ToppCell | Control-Lymphoid-T|Control / Disease state, Lineage and Cell class | 1.71e-04 | 193 | 64 | 4 | af928046ccd1ca874be1534aef6ca7f27d90bc46 | |
| ToppCell | Control-Endothelial-Lymphatic|Control / Disease state, Lineage and Cell class | 1.71e-04 | 193 | 64 | 4 | 64d19be73e5432d491436a01da5de5c926b615a9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.71e-04 | 193 | 64 | 4 | 7deb439943d35a4e825674b2b7dcddb45d366ad1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 193 | 64 | 4 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.71e-04 | 193 | 64 | 4 | 9c9434a3297b85774b4f0ecab6294f44d738e29f | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.74e-04 | 194 | 64 | 4 | 5402835d6b252276e458001949dd1cb5aa744b0e | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.74e-04 | 194 | 64 | 4 | f64da5f62e29253d60b9546edf734ba5c17daae1 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Secretory/RAS|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.74e-04 | 194 | 64 | 4 | 2c0236a102f7fec6d508afec6137da5b26a65931 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 194 | 64 | 4 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | 3'-Child04-06-SmallIntestine-Neuronal|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-04 | 195 | 64 | 4 | 8d286622f86c844d1b06a106ee4a3f813eba05bb | |
| ToppCell | 3'-Child04-06-SmallIntestine-Neuronal-Glial_mature|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-04 | 195 | 64 | 4 | 4193e58788e90c3d1049ef5cf9800a8c4d8ac354 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.77e-04 | 195 | 64 | 4 | 6b6c4a0c713f32c757bd303aa84ec7dc3d825cc8 | |
| Drug | boron trichloride | 9.03e-10 | 6 | 65 | 4 | CID000025135 | |
| Drug | desmethylazelastine | 1.07e-07 | 16 | 65 | 4 | CID000162558 | |
| Drug | dazmegrel | 2.27e-07 | 19 | 65 | 4 | CID000053555 | |
| Drug | YM 026 | 2.27e-07 | 19 | 65 | 4 | CID000004443 | |
| Drug | AZFd | 5.14e-07 | 23 | 65 | 4 | CID000196489 | |
| Drug | dansylaziridine | 5.14e-07 | 23 | 65 | 4 | CID000104008 | |
| Drug | d-gluconhydroximo-1,5-lactam | 1.80e-06 | 31 | 65 | 4 | CID000003479 | |
| Drug | Vistar | 3.33e-06 | 36 | 65 | 4 | CID000040896 | |
| Drug | 3-bromo-7-nitroindazole | 3.33e-06 | 36 | 65 | 4 | CID000001649 | |
| Drug | molybdenum disulfide | 6.87e-06 | 43 | 65 | 4 | CID000014823 | |
| Drug | 2-chlorodideoxyadenosine | 6.87e-06 | 43 | 65 | 4 | CID000072194 | |
| Drug | propham | 7.54e-06 | 44 | 65 | 4 | CID000024685 | |
| Drug | Clorgyline | 8.50e-06 | 168 | 65 | 6 | ctd:D003010 | |
| Drug | ridogrel | 1.48e-05 | 52 | 65 | 4 | CID005362391 | |
| Drug | Pyrantel tartrate [33401-94-4]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.87e-05 | 193 | 65 | 6 | 5088_DN | |
| Drug | Pyrithyldione [77-04-3]; Down 200; 24uM; PC3; HT_HG-U133A | 1.87e-05 | 193 | 65 | 6 | 7153_DN | |
| Drug | Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; PC3; HT_HG-U133A | 2.04e-05 | 196 | 65 | 6 | 7142_DN | |
| Drug | azafagomine | 2.13e-05 | 57 | 65 | 4 | CID011957435 | |
| Drug | TXB2 (thromboxane B2 | 2.21e-05 | 118 | 65 | 5 | CID000005461 | |
| Drug | AC1L28RO | 2.40e-05 | 3 | 65 | 2 | CID000016830 | |
| Drug | 6-dimethylaminophenylazobenzthiazole | 2.40e-05 | 3 | 65 | 2 | CID000029080 | |
| Drug | NSC56408 | 2.98e-05 | 62 | 65 | 4 | CID000005604 | |
| Drug | kt S | 3.82e-05 | 66 | 65 | 4 | CID006399216 | |
| Drug | azelastine | 5.99e-05 | 74 | 65 | 4 | CID000002267 | |
| Drug | nefopam | 6.19e-05 | 27 | 65 | 3 | CID000004450 | |
| Drug | p11-13 | 6.31e-05 | 75 | 65 | 4 | CID000015759 | |
| Drug | rimonabant | 1.09e-04 | 265 | 65 | 6 | ctd:C089032 | |
| Disease | Male sterility due to Y-chromosome deletions | 1.07e-09 | 8 | 60 | 4 | C2931163 | |
| Disease | Partial chromosome Y deletion | 1.07e-09 | 8 | 60 | 4 | C1507149 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 4.39e-06 | 16 | 60 | 3 | C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 4.39e-06 | 16 | 60 | 3 | 415000 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 4.39e-06 | 16 | 60 | 3 | cv:C1839071 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 8.48e-05 | 7 | 60 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | age at first sexual intercourse measurement | 1.27e-04 | 383 | 60 | 6 | EFO_0009749 | |
| Disease | Prostatic Neoplasms | 2.47e-04 | 616 | 60 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.47e-04 | 616 | 60 | 7 | C0376358 | |
| Disease | anemia (implicated_via_orthology) | 4.20e-04 | 15 | 60 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | gout, hyperuricemia | 4.79e-04 | 16 | 60 | 2 | EFO_0004274, EFO_0009104 | |
| Disease | skin hydration measurement | 8.33e-04 | 21 | 60 | 2 | EFO_0009586 | |
| Disease | Neurodevelopmental Disorders | 9.11e-04 | 93 | 60 | 3 | C1535926 | |
| Disease | Weight Gain | 1.19e-03 | 102 | 60 | 3 | C0043094 | |
| Disease | white matter volume measurement | 1.94e-03 | 32 | 60 | 2 | EFO_0008320 | |
| Disease | Mitral valve prolapse | 2.45e-03 | 36 | 60 | 2 | HP_0001634 | |
| Disease | Bladder Neoplasm | 2.94e-03 | 140 | 60 | 3 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 3.00e-03 | 141 | 60 | 3 | C0005684 | |
| Disease | unipolar depression, age at onset | 3.02e-03 | 40 | 60 | 2 | EFO_0003761, EFO_0004847 | |
| Disease | Carcinoma, Transitional Cell | 3.17e-03 | 41 | 60 | 2 | C0007138 | |
| Disease | Multiple Myeloma | 3.32e-03 | 42 | 60 | 2 | C0026764 | |
| Disease | fibroblast growth factor 23 measurement | 3.48e-03 | 43 | 60 | 2 | EFO_0009381 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.70e-03 | 152 | 60 | 3 | DOID:0060041 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VRNELLEKHYKHGSK | 421 | Q7L0X2 | |
| SKKFGNIHYGKVIHS | 566 | Q9H7T0 | |
| FITGKVLEAGDKHYH | 291 | O14639 | |
| HVDVKGYKDGGIHLE | 151 | O00481 | |
| KHDGRVKIGHYVLGD | 6 | P54646 | |
| LQLGHGLKDFVHKTK | 51 | Q9Y5C1 | |
| IVGSQIHFHGKKLKL | 96 | Q13117 | |
| IVGSQIHFHGKKLKL | 96 | Q9NR90 | |
| IESLYQKLHEGHGKT | 96 | Q8TAI7 | |
| RVHYKGHGKTPKDAA | 186 | Q96S59 | |
| KIHSHLSGIQKEIKY | 331 | O75901 | |
| KGSLESEKHQYIIHG | 81 | P55895 | |
| LKGKLVVGHDLKHDF | 81 | Q96AZ6 | |
| HREGKYKDTLHLIGE | 61 | P43631 | |
| HCLKEGLKVYLGKHA | 76 | Q9UKR3 | |
| KAHSGGIKILYHKSL | 481 | Q9H306 | |
| EKDLHLKGYHTLSQG | 66 | Q9H649 | |
| DYLELHIHQGKIGVK | 141 | P58400 | |
| NTKVKSLGHHKGEFL | 96 | Q9H2G9 | |
| KEAHQKAREKYGHLL | 471 | P46199 | |
| TFKYHHVGKLLKEGE | 161 | O00264 | |
| DYLELHIHQGKIGVK | 1176 | Q9ULB1 | |
| EEKNKKFGLSVGHHL | 246 | P15559 | |
| DGEKGQYTHKIYHLK | 51 | P48739 | |
| LQDEGYKKHIKHHCN | 1611 | Q3L8U1 | |
| IVGSQIHFHGKKLKL | 96 | Q9NQZ3 | |
| IVGSQIHFHGKKLKL | 261 | Q9NQZ3 | |
| IVGSQIHFHGKKLKL | 426 | Q9NQZ3 | |
| KGGLKKQHDTLVEYH | 76 | Q07973 | |
| VVLHDDGYKKHLKQH | 1211 | Q8TD26 | |
| LHKHGEKLYTGLREV | 66 | Q13618 | |
| HGKSQDKAITHYLKG | 391 | Q5T764 | |
| LGCYKKLIEYHKNGH | 46 | Q8TDQ7 | |
| EIHGFLHAKEQGKKS | 236 | Q14449 | |
| IVGSQIHFHGKKLKL | 96 | Q86SG3 | |
| IVGSQIHFHGKKLKL | 261 | Q86SG3 | |
| AVFKGQGTKEYEIHH | 421 | Q8IXB1 | |
| QGTKEYEIHHGKKIL | 426 | Q8IXB1 | |
| SRQVDHHEKKKAGYI | 1771 | Q8TDX9 | |
| HHEKKKAGYIFLQEA | 1776 | Q8TDX9 | |
| AYLHSQKKIHRDIKG | 126 | Q92918 | |
| IVESKEKYEHHTGKG | 651 | Q6P4F7 | |
| KEHKLKKGAGYHLDL | 941 | Q9Y6M7 | |
| HLLEAFKGSHKSGKQ | 376 | O75151 | |
| GYMHEKGLGIKQDIH | 671 | Q9UBV2 | |
| QKYGLKSKSHGVGHD | 641 | O15226 | |
| LQKAVKTLKYFDHHG | 376 | Q96DL1 | |
| SKGHVIYEGKSGHIL | 1206 | O75376 | |
| KGLIKDQIFGSHLHK | 271 | Q53QZ3 | |
| HQYSGREGDKHKLKK | 16 | P04271 | |
| KEKLTHKASENGHYE | 321 | O95149 | |
| YGKHLLGVEDLLQKH | 556 | Q01082 | |
| KSADEHKVHKRGYNG | 151 | Q14593 | |
| YIHSKKHVQDVGAPK | 436 | Q2QGD7 | |
| CGHHNLQLKKGYKSV | 106 | A8MTY0 | |
| LNEHKLIHSGEKPYK | 451 | P0CG00 | |
| NGKAYLTEHEKIHTG | 146 | Q3ZCT1 | |
| TLEGTKKGHKLHLDY | 131 | P09486 | |
| KVTSNLEKIHLGYHK | 6 | Q5SVQ8 | |
| ANLYAHKKIHTGEKP | 866 | Q8TF20 | |
| LYAHKKIHTGDKTIQ | 896 | Q8TF20 | |
| GFKYFKNLIAHVKGH | 691 | O60281 | |
| KIHKVGETHEYGENT | 171 | A6NDX5 | |
| YLHQEKKLLHGDIKS | 156 | Q96KB5 | |
| DNKVYIKTHGEHVGF | 196 | Q6UW63 | |
| LNIHKKIHTGGKHFE | 371 | Q5JVG2 | |
| KSHLETHKIIYTGGK | 311 | P17035 | |
| YRTLTNHKKVHLGEK | 601 | Q8NB50 | |
| VNRKEHKLKKGAGYH | 806 | Q9Y6R1 | |
| KEYGKHQGHKHSVLE | 206 | P36406 | |
| DSHYQGKIHAKRLKL | 91 | Q9H898 | |
| DHKGIHTGEKLYEYK | 306 | Q8WXB4 | |
| KYKDGYRKQLGHHIG | 3036 | P20929 | |
| YKEAYEKQKGHHIGA | 3766 | P20929 | |
| DHEKQKGHYVGTLTA | 4011 | P20929 | |
| KAEHVKQKGHYVGVP | 4251 | P20929 |